Article
Azacytidine restores T cell function in AML by modulating DNA methylation
2026-06-17
Abstract excerpt
AML is an aggressive blood cancer associated with poor clinical outcomes. Chemotherapy remains the standard of treatment, but unfortunately relapse is very common, highlighting the need for alternative therapies. T cell dysfunction and exhaustion are prominent in AML and may represent a barrier to effective immunotherapy yet remains poorly studied in AML. DNA methylation is a major driver of T cell exhaustion and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0994dcca-26ce-50ef-b650-a4ca1fa7a09b
- DOI
- 10.64898/2026.06.14.732148
